Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Henry Schein (NASDAQ:HSIC) in the last three months.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

	Bullish	Somewhat Bullish	Indifferent	Somewhat Bearish	Bearish
Total Ratings	0	2	2	0	0
Last 30D	0	0	1	0	0
1M Ago	0	1	0	0	0
2M Ago	0	0	1	0	0
3M Ago	0	1	0	0	0

The 12-month price targets, analyzed by analysts, offer insights with an average target of $88.5, a high estimate of $100.00, and a low estimate of $81.00. This upward trend is apparent, with the current average reflecting a 16.96% increase from the previous average price target of $75.67.

Exploring Analyst Ratings: An In-Depth Overview

The standing of Henry Schein among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
Michael Cherny	Leerink Partners	Raises	Market Perform	$87.00	$75.00
Jeff Johnson	Baird	Raises	Outperform	$100.00	$78.00
Steven Valiquette	Mizuho	Raises	Neutral	$81.00	$74.00
Glen Santangelo	Barclays	Announces	Overweight	$86.00	-

Key Insights:

• Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Henry Schein. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Henry Schein compared to the broader market.
• Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Henry Schein's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Henry Schein's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Henry Schein analyst ratings.

Delving into Henry Schein's Background

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Financial Milestones: Henry Schein's Journey

Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.

Positive Revenue Trend: Examining Henry Schein's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.2% as of 30 September, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: Henry Schein's net margin is impressive, surpassing industry averages. With a net margin of 3.02%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.97%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): Henry Schein's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.92%, the company showcases efficient use of assets and strong financial health.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.02.

How Are Analyst Ratings Determined?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.